Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/american-medical-association/effect-of-dasatinib-vs-imatinib-in-the-treatment-of-pediatric-7l6ovDdyEv
References (39)
-
K. Schultz, A. Carroll, N. Heerema, W. Bowman, A. Aledo, W. Slayton, H. Sather, M. Devidas, H. Zheng, S. Davies, P. Gaynon, M. Trigg, R. Rutledge, D. Jorstad, N. Winick, M. Borowitz, S. Hunger, W. Carroll, B. Camitta (2014)
Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031Leukemia, 28
-
M. Zelen (1974)
The randomization and stratification of patients to clinical trials.Journal of chronic diseases, 27 7-8
-
Pui Ch, D. Pei, D. Campana, C. Cheng, J. Sandlund, W. Bowman, M. Hudson, Raul Ribeiro, S. Raimondi, S. Jeha, S. Howard, D. Bhojwani, H. Inaba, J. Rubnitz, M. Metzger, T. Gruber, E. Coustan-Smith, J. Downing, W. Leung, M. Relling, W. Evans (2014)
A Revised Definition for Cure of Childhood Acute Lymphoblastic LeukemiaLeukemia, 28
-
F. Ravandi, M. Othus, S. O'brien, S. Forman, C. Ha, J. Wong, M. Tallman, E. Paietta, J. Racevskis, G. Uy, M. Horowitz, N. Takebe, R. Little, U. Borate, P. Kebriaei, L. Kingsbury, H. Kantarjian, J. Radich, H. Erba, F. Appelbaum (2016)
US Intergroup Study of Chemotherapy Plus Dasatinib and Allogeneic Stem Cell Transplant in Philadelphia Chromosome Positive ALL.Blood advances, 1 3
-
C. Pui, D. Campana, D. Pei, W. Bowman, J. Sandlund, S. Kaste, Raul Ribeiro, J. Rubnitz, S. Raimondi, M. Onciu, E. Coustan-Smith, L. Kun, S. Jeha, Cheng Cheng, S. Howard, V. Simmons, A. Bayles, M. Metzger, J. Boyett, W. Leung, R. Handgretinger, J. Downing, W. Evans, M. Relling (2009)
Treating childhood acute lymphoblastic leukemia without cranial irradiation.The New England journal of medicine, 360 26
-
J. Wolf, Li Tang, P. Flynn, C. Pui, A. Gaur, Yilun Sun, H. Inaba, Tracy Stewart, R. Hayden, H. Hakim, S. Jeha (2017)
Levofloxacin Prophylaxis During Induction Therapy for Pediatric Acute Lymphoblastic LeukemiaClinical Infectious Diseases, 65
-
A. Biondi, M. Schrappe, P. Lorenzo, A. Castor, G. Lucchini, V. Gandemer, R. Pieters, J. Starý, G. Escherich, M. Campbell, Chi-kong Li, A. Vora, M. Aricò, S. Röttgers, V. Saha, M. Valsecchi (2012)
Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup studyThe Lancet. Oncology, 13
-
S. Schlieben, A. Borkhardt, I. Reinisch, J. Ritterbach, J. Janssen, R. Ratei, M. Schrappe, R. Repp, M. Zimmermann, H. Kabisch, G. Janka-Schaub, C. Bartram, W. Ludwig, H. Riehm, F. Lampert, J. Harbott (1996)
Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92.Leukemia, 10 6
-
A. Manabe, H. Kawasaki, H. Shimada, I. Kato, Y. Kodama, A. Sato, Kimikazu Matsumoto, Keisuke Kato, H. Yabe, K. Kudo, Motohiro Kato, Tomohiro Saito, A. Saito, M. Tsurusawa, K. Horibe (2015)
Imatinib use immediately before stem cell transplantation in children with Philadelphia chromosome-positive acute lymphoblastic leukemia: Results from Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) Study Ph+ALL04Cancer Medicine, 4
-
K. Porkka, Perttu Koskenvesa, T. Lundán, J. Rimpiläinen, S. Mustjoki, Richard Smykla, R. Wild, R. Luo, M. Arnán, B. Brethon, L. Eccersley, H. Hjorth-Hansen, M. Höglund, H. Klamová, H. Knutsen, S. Parikh, E. Raffoux, F. Gruber, F. Brito-Babapulle, H. Dombret, Rafael Duarte, E. Elonen, R. Paquette, C. Zwaan, Frank Lee (2008)
Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia.Blood, 112 4
-
J. Gotlib (2017)
A molecular roadmap for midostaurin in mastocytosis.Blood, 130 2
-
J. Cai, Jie Yu, Xiaofan Zhu, Shaoyan Hu, Yiping Zhu, Hua Jiang, Chunfu Li, Yongjun Fang, Changda Liang, X. Ju, Xin Tian, X. Zhai, Jinjin Hao, Q. Hu, Ningling Wang, Huiyan Jiang, Lirong Sun, Chi-kong Li, K. Pan, Minghua Yang, S. Shen, Cheng Cheng, R. Ribeiro, C. Pui, Jingyan Tang (2019)
Treatment abandonment in childhood acute lymphoblastic leukaemia in China: a retrospective cohort study of the Chinese Children’s Cancer GroupArchives of Disease in Childhood, 104
-
M. Aricò, M. Schrappe, S. Hunger, W. Carroll, V. Conter, S. Galimberti, A. Manabe, V. Saha, A. Baruchel, K. Vettenranta, K. Horibe, Y. Benoît, R. Pieters, G. Escherich, L. Silverman, C. Pui, M. Valsecchi (2008)
Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28 31
-
S. Jeha, E. Coustan-Smith, D. Pei, J. Sandlund, J. Rubnitz, S. Howard, H. Inaba, D. Bhojwani, M. Metzger, Cheng Cheng, J. Choi, J. Jacobsen, S. Shurtleff, S. Raimondi, R. Ribeiro, C. Pui, D. Campana (2014)
Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome‐positive acute lymphoblastic leukemiaCancer, 120
-
J. Kalbfleisch, R. Prentice (2002)
The Statistical Analysis of Failure Time Data: Kalbfleisch/The Statistical -
N. Short, H. Kantarjian, C. Pui, A. Goldstone, E. Jabbour (2018)
SOHO State of the Art Update and Next Questions: Philadelphia Chromosome‐Positive Acute Lymphoblastic LeukemiaClinical Lymphoma, Myeloma & Leukemia, 18
-
Hunger (2017)
CA180-372: an international collaborative phase 2 trial of dasatinib and chemotherapy in pediatric patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL).Blood, 130
-
K. Duncan, R. Abudu, M. Cira, D. Pyle (2019)
Global Oncology Research and Training Collaborations Led by the National Cancer Institute (NCI)–Designated Cancer Centers: Results From the 2018 NCI/ASCO Global Oncology Survey of NCI-Designated Cancer CentersJournal of Global Oncology
-
F. Ravandi, S. O'brien, J. Cortes, Deborah Thomas, Rebecca Garris, S. Faderl, J. Burger, M. Rytting, A. Ferrajoli, W. Wierda, S. Verstovsek, R. Champlin, P. Kebriaei, Deborah McCue, Xuelin Huang, E. Jabbour, G. Garcia-Manero, Z. Estrov, H. Kantarjian (2015)
Long‐term follow‐up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome–positive acute lymphoblastic leukemiaCancer, 121
-
Pui (2011)
Treatment of childhood acute lymphoblastic leukemia without cranial irradiation.Ann Hematol, 90
-
C. Pui, W. Evans (2006)
Treatment of acute lymphoblastic leukemia.The New England journal of medicine, 354 2
-
H. Kantarjian, J. Cortes, Dong-Wook Kim, P. Dorlhiac-Llacer, R. Pasquini, J. Dipersio, M. Müller, J. Radich, H. Khoury, N. Khoroshko, M. Bradley-Garelik, Chao Zhu, M. Tallman (2009)
Phase 3 study of dasatinib 140 mg once daily versus 70 mg twice daily in patients with chronic myeloid leukemia in accelerated phase resistant or intolerant to imatinib : 15-month median follow-up -
J. Fine, R. Gray (1999)
A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 94
-
Michinori Aoe, H. Ishida, Takehiro Matsubara, S. Karakawa, H. Kawaguchi, Kaori Fujiwara, Kiichiro Kanamitsu, K. Washio, Ken Okada, M. Shibakura, A. Shimada (2018)
Simultaneous detection of ABL1 mutation and IKZF1 deletion in Philadelphia chromosome‐positive acute lymphoblastic leukemia using a customized target enrichment system panelInternational Journal of Laboratory Hematology, 40
-
Ting-Chi Yeh, Hsi-Che Liu, Jen-Yin Hou, Kuan-Hao Chen, Ting-Huan Huang, Ching-Yi Chang, D. Liang (2014)
Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxisCancer, 120
-
T. O'hare, D. Walters, E. Stoffregen, Taiping Jia, P. Manley, J. Mestan, S. Cowan-Jacob, F. Lee, M. Heinrich, M. Deininger, B. Druker (2005)
In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants.Cancer research, 65 11
-
R. Gray (1988)
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing RiskAnnals of Statistics, 16
-
W. Slayton, K. Schultz, J. Kairalla, M. Devidas, X. Mi, M. Pulsipher, B. Chang, C. Mullighan, I. Iacobucci, L. Silverman, M. Borowitz, A. Carroll, N. Heerema, J. Gastier-Foster, B. Wood, Sherri Mizrahy, T. Merchant, V. Brown, L. Sieger, M. Siegel, E. Raetz, N. Winick, M. Loh, W. Carroll, S. Hunger (2018)
Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0622.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 36 22
-
O. Singh, J. Chan, Keegan Lin, C. Heng, B. Chowbay (2012)
SLC22A1-ABCB1 Haplotype Profiles Predict Imatinib Pharmacokinetics in Asian Patients with Chronic Myeloid LeukemiaPLoS ONE, 7
-
Pui (2019)
International collaboration to save children with acute lymphoblastic leukemia.J Glob Oncol, 5
-
T. Freedman, H. Lynch, S. Lemon, S. Tinley, J. Lynch, P. Watson (1997)
Psychologic Aspects of Cancer Genetic Testing: A Research Update for Clinicians -
J. Kalbfleisch, R. Prentice (1980)
The Statistical Analysis of Failure Time Data -
Piccaluga (2007)
Tyrosine kinase inhibitors for the treatment of Philadelphia chromosome?positive adult acute lymphoblastic leukemia.Cancer, 110
-
O. Ottmann, H. Dombret, G. Martinelli, B. Simonsson, F. Guilhot, R. Larson, G. Rege‐Cambrin, J. Radich, A. Hochhaus, A. Apanovitch, A. Gollerkeri, S. Coutre (2007)
Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia with resistance or intolerance to imatinib: interim results of a phase 2 study.Blood, 110 7
-
A. Biondi, V. Gandemer, P. Lorenzo, G. Cario, M. Campbell, A. Castor, R. Pieters, A. Baruchel, A. Vora, V. Leoni, J. Starý, G. Escherich, Chi-kong Li, G. Cazzaniga, H. Cavé, J. Bradtke, V. Conter, V. Saha, M. Schrappe, Maria Valsecchi (2018)
Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial.The Lancet. Haematology, 5 12
-
K. Schultz, W. Bowman, A. Aledo, W. Slayton, H. Sather, M. Devidas, Chenguang Wang, S. Davies, P. Gaynon, M. Trigg, R. Rutledge, Laura Burden, D. Jorstad, A. Carroll, N. Heerema, N. Winick, M. Borowitz, S. Hunger, W. Carroll, B. Camitta (2009)
Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 31
-
Yi-Jin Gao, Ye Guo, Shaoyan Hu, Yiping Zhu, Q. Hu, Jie Yu, H. He, Y. Ai, A. Zhang, Y. Xian, Jing Chen, Xiao-Fan Zhu (2016)
Philadelphia chromosome-positive acute lymphoblastic leukemia in China: a retrospective study from the Chinese Childhood Cancer GroupLeukemia & Lymphoma, 57
-
Yin Liu, J. Chen, Jingyan Tang, Shengxing Ni, H. Xue, C. Pan (2009)
Cost of childhood acute lymphoblastic leukemia care in Shanghai, ChinaPediatric Blood & Cancer, 53
-
M. Aricò, M. Valsecchi, B. Camitta, M. Schrappe, J. Chessells, A. Baruchel, P. Gaynon, L. Silverman, G. Janka-Schaub, W. Kamps, Pui Ch, G. Masera (2000)
Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia.The New England journal of medicine, 342 14
- Publisher
- American Medical Association
- Copyright
- Copyright 2020 American Medical Association. All Rights Reserved.
- ISSN
- 2374-2437
- eISSN
- 2374-2445
- DOI
- 10.1001/jamaoncol.2019.5868
- Publisher site
- See Article on Publisher Site
Abstract
This phase 3 randomized clinical trial assesses whether dasatinib given at 80 mg/m2 is more effective than imatinib mesylate at 300 mg/m2 to improve event-free survival in children with Philadelphia chromosome–positive acute lymphoblastic leukemia.
Journal
JAMA Oncology – American Medical Association
Published: Mar 16, 2020